In oncology, technologies for clinical molecular imaging are used to diagnose patients,
establish the efficacy of treatments and monitor the recurrence of disease. Multiplexed …

Theranostics has emerged in recent years to provide an efficient and safer alternative in
cancer management. This review presents an updated description of nanotheranostic …

Recent advancements in RNA therapeutics highlight the critical need for precision gene
delivery systems that target specific organs and cells. Lipid nanoparticles (LNPs) have …

Polymeric micelles are a prevalent topic of research for the past decade, especially
concerning their fitting ability to deliver drug and diagnostic agents. This delivery system …

Imaging and tracking biological targets or processes play an important role in revealing
molecular mechanisms and disease states. Bioimaging via optical, nuclear, or magnetic …

Background Hyaluronic acid (HA) has been widely used as one of major components of
nanocarriers for cancer imaging and therapy. HA possesses hydrophilic and anionic …

The clinical impact and accessibility of 68Ga tracers for the prostate-specific membrane
antigen (PSMA) and other targets would be greatly enhanced by the availability of a simple …

Combination chemotherapy is commonly used to treat advanced breast cancer. However,
treatment success is often limited due to systemic toxicity. To improve therapeutic efficacy …

Since the last decade, the polymer-drug conjugate (PDC) approach has emerged as one of
the most promising drug-delivery technologies owing to several benefits like circumventing …

Glioblastoma is an unmet clinical need. Local treatment strategies offer advantages, such as
the possibility to bypass the blood–brain barrier, achieving high drug concentrations at the …